ARCHIVES

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Revitalization Act Authorizes $3 Billion For NCI In FY97

July 5, 1996

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

June 2, 2006

NCI contract Award

August 1, 1997

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

CCOPs Favor Ability To Enter Patients On Any Group Study

June 12, 1998

Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds

December 26, 2008